• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Some can combat dementia by enlisting still-healthy parts of the brain

Bioengineer by Bioengineer
April 11, 2018
in Health
Reading Time: 4 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Aneta Kielar, University of Arizona

People with a rare dementia that initially attacks the language center of the brain recruit other areas of the brain to decipher sentences, according to new research led by a University of Arizona cognitive scientist.

The study is one of the first to show that people with a neurodegenerative disease can call upon intact areas of the brain for help. People who have had strokes or traumatic brain injuries sometimes use additional regions of the brain to accomplish tasks that were handled by the now-injured part of the brain.

"We were able to identify regions of the brain that allowed the patients to compensate for the dying of neurons in the brain," said first author Aneta Kielar, a UA assistant professor of speech, language and hearing sciences and of cognitive science.

The type of the dementia the researchers tested, primary progressive aphasia, or PPA, is unusual because it starts by making it hard for people to process language, rather than initially harming people's memory.

Kielar and her colleagues used magnetoencephalography, or MEG, to track how the 28 study participants' brains responded when confronted with several different language tasks. MEG revealed which part of the participant's brain responded and how fast the person's brain responded to the task.

People typically rely on the left side of the brain to comprehend language. Some of the people with PPA who were tested showed additional brain activity on the right, and those people did better on the language tests.

Senior author Jed Meltzer said, "These findings offer hope since it demonstrates that despite the brain's degeneration during PPA, the brain naturally adapts to try and preserve function."

Meltzer, a scientist at the Rotman Research Institute of the Baycrest Health Sciences Toronto, in Ontario, Canada, and Canada Research Chair in Interventional Cognitive Neuroscience, added, "This brain compensation suggests there are opportunities to intervene and offer targeted treatment to those areas."

Kielar conducted the research as a part of a postdoctoral fellowship at the Rotman Research Institute.

Kielar's and Meltzer's co-authors on the paper, "Abnormal language-related oscillatory responses in primary progressive aphasia," are Regina Jokel and Tiffany Deschamps of the University of Toronto. The journal NeuroImage: Clinical published the paper online in March.

The Ontario Brain Institute, the Alzheimer's Association, the Ontario Research Coalition and the Sandra A. Rotman program in Cognitive Neuroscience funded the research.

Kielar became intrigued by PPA because its effects on language are so different from other dementias. PPA's unusual characteristics also make it hard to diagnose, she said.

At the early stages of the disease, people with PPA can drive, go to the grocery store by themselves and do other things that require working memory, but they have trouble reading, writing and speaking grammatical sentences, she said.

"PPA specifically attacks language initially," she said. "I wanted to know what is special about the language regions of the brain."

Previous research using electroencephalograms, or EEGs, of PPA patients showed as the disease progressed, something at the neuronal level became slower. However, EEGs do not provide information about which brain region is slowing.

Therefore Kielar and her colleagues used MEG to take images of the brains of 28 people–13 people with PPA and 15 age-matched healthy controls–as they read sentences on an LCD screen. Some of the sentences had grammatical errors or mismatched words.

The researchers also conducted MRI scans of each participant to map each person's brain.

Working brains generate tiny changes in magnetic fields. MEG records those tiny, millisecond changes in magnetic fields that occur as the brain processes information. The MEG machinery is so sensitive that it requires a special shielded room that prevents any outside magnetic fields–such as those from electric motors, elevators, and even the Earth's magnetic field–from entering.

MEG can tell both when the brain was working on a task and what region of the brain was doing the task, Kielar said.

She and her colleagues found the brains of people with PPA responded more slowly to the language tests, which was not known before.

"You can tell that they are struggling, but we did not know that the neural processing in the brain was slowed down," she said. "It seems that this delay in processing may account for some of the deficits they have in processing language."

She and her colleagues hope knowing which parts of the brain are damaged by PPA will help develop a treatment. There is no cure for PPA, she said.

Transcranial magnetic stimulation, or TMS, a non-invasive treatment that sends a magnetic pulse to specific brain regions, has helped people who have had strokes. Kielar and her colleagues are planning to see if TMS can slow the progression of PPA.

###

The team's research paper is open access and can be found here: https://www.sciencedirect.com/science/article/pii/S2213158218300627

Researcher contact:

Aneta Kielar
University of Arizona
520-621-5105
[email protected] Languages: English, Polish

Media contact:

Mari N. Jensen
University of Arizona
520-626-9636
[email protected]

Media contacts for Baycrest Health Sciences:

Jonathan MacIndoe
416-785-2500 ext. 6579
[email protected]

Michelle Petch Gotuzzo
416-785-2500 ext. 6932
[email protected]

Media Contact

Mari N. Jensen
[email protected]
520-626-9635
@UofA

http://uanews.org

Related Journal Article

http://dx.doi.org/10.1016/j.nicl.2018.02.028

Share12Tweet8Share2ShareShareShare2

Related Posts

New Smartphone App Designed by Mental Health Researchers Enhances Mental Habits and Cognitive Function in Controlled Trial

April 2, 2026

Impact of Unionization and Ownership on Turnover Rates Among Direct Care Workers

April 2, 2026

Nanotechnology Reprograms Skin Environment in Scars, Dermatitis

April 2, 2026

Global Virus Network Meeting Propels Science-Driven Pandemic Preparedness Agenda

April 2, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Insights into CD4+ T-Cell Depletion and Pulmonary Infections in Critically Ill Immunocompromised Patients

Lentinus edodes-Derived β-Glucan Suppresses Human Cervical Cancer Progression via DMBT1 Pathway

Advanced Sensors Reduce Costs in Genetic Disorder Research

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.